2025 CME Information
3.00 Credits Available
1.00 CME Credits
May 29, 2025, 9:30-10:30 am (EST)
Rethinking Cannabis Use Disorder Treatment: Individualized Risks, Benefits, and Care
Dr. Rachel Tomko
1.00 CME Credits
May 29, 2025, 1:15-2:15 pm (EST)
Effects of Edible Cannabis Use on Pain, Sleep, and Mood
Dr. Angela Bryan
1.00 CME Credits
May 30, 2025, 9:15-10:15 am (EST)
Developing Cannabis-Based Treatments for Chemotherapy-Induced Peripheral Neuropathy and Adjuvant Anti-Tumor Activity
Dr. Sara Jane Ward
- Learning objectives: As a result of participation in this activity, participants will be able to learn about:
- Learn about the risks and benefits of certain cannabis use disorder treatments
- Learn about the effects of edible cannabis use on pain, sleep, and mood
- Learn about the cannabis based treatments being developed for cancer patients
- Target audience: Primary care physicians and specialty physicians
- Accreditation statement: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- Credit statement: The University of Florida College of Medicine designates this live activity for a maximum of 3.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Commercial support (grant/exhibit) acknowledgement:
- This conference is supported by:
- Exhibits: Karger Publishers, Office of Medical Marijuana Use, Innovations for Substance Use Disorders
- Grants: None
- Disclosure statement: No one in a position to control content has any financial relationships to disclose. Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/. All relevant financial relationships have been mitigated.